FDA Approves CLINDAMYCIN PHOSPHATE — Padagis Israel Pharmaceuticals Ltd

Padagis Israel Pharmaceuticals Ltd reported the approval of its 505(b)(2) application (and label extension) for topical clindamycin phosphate to market a generic version of Cleocin T Lotion. The expanded route may provide the manufacturer with broader market potential and heighten competitive dynamics in the acne treatment sector.